| Issue |
Med Sci (Paris)
Volume 39, Number 8-9, Août–Septembre 2023
|
|
|---|---|---|
| Page(s) | 599 - 602 | |
| Section | Nouvelles | |
| DOI | https://doi.org/10.1051/medsci/2023091 | |
| Published online | 11 septembre 2023 | |
Les séquanamycines, puissants macrolides oraux anti-tuberculeux dérivés d’un produit naturel
Discovery of natural product-derived sequanamycins as potent oral anti-tuberculosis agents
1
Sanofi R&D, Infectious diseases unit, 31036 Toulouse, France
2
Evotec ID (LYON) SAS, Lyon, France
3
Sanofi R&D, Integrated drug discovery, Vitry-sur-Seine, France
* Cette adresse e-mail est protégée contre les robots spammeurs. Vous devez activer le JavaScript pour la visualiser.
Cet article ne possède pas de résumé.
© 2023 médecine/sciences – Inserm
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.
